health
cardiovascular
pulmonari
system
inextric
link
reninangiotensin
system
ra
physiolog
speak
balanc
vasodeleteri
aceang
iiat
r
vasoprotect
masr
compon
ra
critic
cardiopulmonari
homeostasi
upregul
aceang
iiat
r
axi
shift
system
toward
vasoconstrict
prolifer
hypertrophi
inflamm
fibrosi
factor
contribut
develop
progress
cardiopulmonari
diseas
convers
stimul
vasoprotect
masr
axi
produc
counterregulatori
respons
promot
cardiovascular
health
current
research
investig
novel
strategi
augment
action
vasoprotect
ra
compon
particularli
order
treat
variou
patholog
multipl
approach
increas
activ
display
benefici
effect
experiment
diseas
model
mechan
behind
protect
action
remain
incomplet
understood
recent
work
demonstr
noncatalyt
role
amino
acid
transport
gut
led
us
specul
therapeut
effect
mediat
part
action
gastrointestin
tract
andor
gut
microbiom
consist
emerg
data
suggest
dysbiosi
gut
lung
microbiom
associ
cardiopulmonari
diseas
review
highlight
new
develop
protect
action
cardiopulmonari
disord
discuss
innov
approach
target
therapi
explor
evolv
role
gut
lung
microbiota
cardiopulmonari
health
circul
reninangiotensin
system
ra
hormon
system
play
promin
role
regul
blood
pressur
bp
maintain
fluid
balanc
bodi
wherea
local
express
ra
organ
tissu
promot
growth
differenti
inflamm
angiotensin
ii
ang
ii
potent
vasoconstrictor
major
effector
peptid
system
form
result
enzymat
cleavag
angiotensin
ang
angiotensin
convert
enzym
ace
figur
ang
ii
exert
action
via
bind
two
distinct
gprotein
coupl
receptor
angiotensin
type
receptor
r
angiotensin
type
receptor
r
apart
regul
bp
overact
ra
implic
develop
progress
numer
cardiovascular
cv
pathophysiolog
fact
ace
inhibitor
acei
angiotensin
receptor
blocker
arb
first
line
treatment
patient
hypertens
cardiovascular
diseas
cvd
agent
effect
bp
lower
well
attenu
ventricular
remodel
reduc
incid
myocardi
infarct
mi
prevent
develop
heart
failur
hf
recent
discoveri
sever
new
ra
compon
alter
way
ra
perceiv
field
particular
signific
identif
angiotensin
convert
enzym
monocarboxypeptidas
cleav
ang
ii
angiotensin
ang
ang
vasodilatori
heptapeptid
act
ma
receptor
masr
mediat
antiprolif
antifibrot
antiinflammatori
effect
observ
led
propos
angiotensin
system
compos
two
oppos
arm
ace
ang
ii
r
repres
deleteri
axi
aceang
iiat
r
wherea
ang
masr
repres
benefici
axi
masr
figur
physiolog
condit
exist
balanc
two
axe
aid
mainten
cardiopulmonari
homeostasi
upregul
vasodeleteri
axi
lead
vasoconstrict
hypertrophi
inflamm
cardiac
remodel
contrast
stimul
vasoprotect
ra
axi
either
genet
overexpress
peptid
infus
administr
synthet
molecul
yield
valuabl
cardiopulmonari
effect
despit
benefici
action
vasoprotect
axi
restor
cardiopulmonari
function
mechan
mediat
protect
complet
understood
review
present
evid
direct
indirect
action
cardiopulmonari
system
effect
cardiac
pulmonari
tissu
includ
vasodil
antihypertrophi
antiprolifer
antifibrosi
figur
furthermor
treatment
shown
improv
endotheli
function
facilit
angiogenesi
enhanc
progenitor
cell
function
promot
cardiopulmonari
health
addit
exert
favor
action
bone
marrow
bm
brain
gastrointestin
system
provid
indirect
benefit
cardiopulmonari
system
regard
action
bm
improv
migratori
potenti
stemprogenitor
cell
aid
regener
injur
cardiopulmonari
tissu
also
increas
nitric
oxid
product
bmderiv
progenitor
cell
enhanc
vascular
repair
similarli
act
brain
improv
baroreflex
sensit
reduc
sympathet
outflow
decreas
bp
gener
believ
benefit
heart
lung
brain
progenitor
cell
primarili
mediat
reduct
ang
ii
subsequ
elev
ang
level
howev
factor
may
involv
well
recent
work
highlight
noncatalyt
role
amino
acid
transport
express
antimicrobi
peptid
gut
along
role
gut
lung
microbiota
promot
cardiorespiratori
health
rapidli
emerg
thu
propos
might
also
exhibit
cardiopulmonari
protect
via
alter
gut
andor
lung
microbiom
may
open
new
avenu
therapeut
intervent
review
discuss
current
understand
role
cardiopulmonari
diseas
discuss
variou
strategi
target
enzym
translat
applic
explor
concept
benefici
effect
cardiopulmonari
disord
may
mediat
chang
microbiota
purpos
extens
search
perform
literatur
last
year
util
pubm
scholarli
search
bibliograph
databas
varieti
term
includ
renin
angiotensin
system
pulmonari
hypertens
cv
diseas
microbiota
multitud
research
focus
role
cv
system
given
map
defin
quantit
trait
locu
x
chromosom
differ
anim
model
hypertens
sever
studi
carri
investig
whether
common
singlenucleotid
polymorph
human
locu
correl
chang
bp
cardiac
function
observ
variant
significantli
associ
essenti
hypertens
femal
hanchines
male
furthermor
patel
et
al
report
genet
variat
caucasian
type
diabet
associ
hypertens
reduc
systol
function
men
wherea
variat
women
associ
hypertens
increas
left
ventricular
lv
mass
genderspecif
data
especi
interest
light
new
evid
partial
loss
xlink
enhanc
suscept
heart
diseas
hd
respons
cv
stressor
furthermor
line
find
sever
group
shown
polymorph
gene
link
cardiac
hypertrophi
howev
discrep
exist
variou
studi
regard
associ
polymorph
hypertens
cardiac
function
inconsist
may
aris
differ
gender
ethnic
etiolog
subject
popul
consider
nonetheless
observ
emphas
import
gene
regul
cv
function
cvd
lead
caus
death
men
women
unit
state
etiolog
diseas
complex
wellestablish
develop
progress
cvd
acceler
action
ang
ii
one
mechan
thought
prevent
endorgan
damag
via
degrad
ang
ii
regard
reduc
gene
express
favor
increas
level
ang
ii
promot
tissu
injuri
content
support
sever
anim
studi
instanc
increas
concentr
cardiac
ang
ii
reduc
level
myocardi
ang
observ
knockout
mice
geneabl
mice
display
enhanc
suscept
cardiac
problem
subject
chronic
ang
ii
infus
pressur
overload
furthermor
studi
reveal
mice
exhibit
maladapt
cardiac
remodel
term
increas
ventricular
hypertrophi
excess
fibrosi
heighten
superoxid
product
decreas
cardiac
contractil
separ
studi
trask
et
al
demonstr
chronic
inhibit
result
excess
accumul
cardiac
ang
ii
worsen
ventricular
remodel
transgen
rat
subsequ
report
sahara
et
al
reveal
delet
promot
develop
atherosclerosi
arteri
neointima
format
highlight
import
confer
vascular
protect
convers
overexpress
myocardium
treatment
recombin
human
protein
prevent
cardiac
remodel
follow
chronic
ang
ii
infus
pressur
overload
mi
preliminari
studi
lab
demonstr
global
overexpress
mice
reduc
cardiac
injuri
remodel
follow
mi
unpublish
data
find
consist
previou
report
illustr
adenoviralmedi
overexpress
result
decreas
ace
ang
ii
myocardium
likewis
treatment
caus
enhanc
plasma
ang
level
along
reduc
plasma
myocardi
ang
ii
data
suggest
express
essenti
cv
protect
express
variou
cellular
compart
heart
includ
cardiac
endotheli
cell
vascular
smooth
muscl
cell
well
cardiomyocyt
observ
express
highli
regul
patholog
stimuli
tissu
insult
regard
anim
studi
reveal
increas
level
mrna
protein
follow
myocardi
injuri
consist
find
zisman
et
al
demonstr
protein
activ
significantli
elev
fail
human
heart
result
increas
ang
decreas
ang
ii
level
also
found
upregul
idiopath
dilat
ischem
cardiomyopathi
howev
due
complex
cvd
etiolog
express
fail
human
heart
remain
controversi
nonetheless
observ
suggest
elev
cardiac
level
could
serv
compensatori
mechan
imped
progress
hf
tradit
thought
tissuebound
enzym
howev
recent
report
detect
measur
solubl
circul
human
plasma
fact
activ
found
increas
patient
hd
posit
correl
diseas
sever
end
systol
diamet
end
diastol
diamet
infarct
size
wherea
correl
neg
eject
fraction
interestingli
activ
also
elev
hypertens
patient
impend
hf
thu
could
potenti
biomark
cardiac
dysfunct
patient
hypertens
hf
howev
recent
work
shao
et
al
appear
run
counter
idea
increas
activ
suggest
worsen
diseas
studi
found
increas
baselin
level
follow
intens
medic
therapi
acut
decompens
hf
patient
predict
improv
clinic
outcom
specul
discrep
may
due
differ
etiolog
patient
popul
diseas
stage
medic
therapi
dispar
warrant
investig
current
evid
highli
indic
cardioprotect
role
human
suggest
differenti
regul
may
import
function
consequ
cvd
role
brain
develop
perpetu
cvd
name
hypertens
hf
well
establish
wide
express
brain
particularli
area
involv
regul
cv
function
wherea
activ
plasma
appear
increas
patholog
state
express
found
consider
reduc
brain
anim
hypertens
neurogen
hypertens
chronic
hf
consist
studi
show
gene
delet
brain
region
led
impair
baroreflex
autonom
function
hand
genet
overexpress
brain
decreas
bp
reduc
sympathet
outflow
increas
baroreflex
sensit
attenu
neurogen
hypertens
addit
brain
overexpress
increas
express
endotheli
neuron
nitric
oxid
synthas
augment
releas
reduc
proinflammatori
cytokin
decreas
reactiv
oxygen
speci
factor
contribut
lower
bp
data
support
role
regul
cv
function
via
action
brain
becom
evid
interplay
organ
bmderiv
circul
cell
critic
diseas
prevent
number
cardiopulmonari
disord
document
imbal
circul
level
repar
inflammatori
cell
ic
contribut
inflamm
impair
vascular
repair
begun
investig
central
mechan
involv
regul
bmderiv
cell
retrograd
neuron
trace
via
inject
pseudorabi
viru
bm
establish
function
connect
brain
bm
studi
group
demonstr
interact
autonom
nervou
system
bm
dysfunct
hypertens
rat
find
associ
increas
ic
decreas
endotheli
progenitor
cell
epc
progenitor
cell
specif
epc
vital
vascular
endotheli
repair
reduc
number
function
epc
observ
patient
cardiopulmonari
diseas
vasoprotect
ra
demonstr
role
improv
number
function
progenitor
cell
fact
anim
treat
activ
diminazen
acetur
dize
display
increas
circul
epc
level
improv
engraft
cardiac
progenitor
cell
heart
decreas
ic
infarct
heart
dize
also
normal
decreas
epc
prolifer
migrat
associ
monocrotalin
mct
induc
pulmonari
arteri
hypertens
pah
consist
epc
patient
pah
demonstr
reduct
migratori
potenti
vitro
improv
dize
treatment
similarli
genet
modif
umbil
cord
deriv
mesenchym
stem
cell
msc
yield
cardiopulmonari
protect
effect
work
group
demonstr
product
significantli
increas
bmderiv
msc
overexpress
ang
figur
thu
vital
function
balanc
circul
progenitor
cell
ic
benefit
ra
vasoprotect
axi
limit
cv
system
studi
past
year
highlight
salutari
effect
lung
pathophysiolog
regard
pulmonari
diseas
came
promin
identifi
function
receptor
sar
coronaviru
sarscov
etiolog
agent
sever
acquir
respiratori
syndrom
sar
observ
sar
infect
reduc
pulmonari
express
also
lead
lung
failur
death
connect
express
lung
pathophysiolog
support
studi
conduct
mice
demonstr
increas
suscept
acut
lung
injuri
recent
also
implic
protect
influenzainduc
lung
injuri
instanc
defici
worsen
diseas
pathogenesi
virusinduc
lung
injuri
addit
mice
display
increas
sever
lung
injuri
consist
evid
infect
decreas
lung
express
wildtyp
mice
furthermor
patient
exhibit
increas
level
serum
ang
ii
find
recapitul
murin
model
infect
interestingli
treatment
restor
lung
function
null
mice
follow
lung
pathogenesi
taken
togeth
data
suggest
pulmonari
protect
treatment
target
enzym
might
effect
attenu
acut
lung
injuri
pah
fatal
lung
diseas
character
increas
bp
pulmonari
circul
grow
bodi
work
focus
import
pah
associ
right
hf
decreas
lung
express
enzymat
activ
along
increas
circul
ang
ii
level
observ
pah
addit
reduct
circul
ang
level
observ
patient
pah
congenit
hd
moreov
autoantibodi
predispos
patient
connect
tissu
diseas
develop
pah
clinic
find
suggest
enhanc
could
provid
pulmonari
protect
regard
anim
studi
shown
overexpress
administr
attenu
pah
associ
improv
structur
function
chang
right
heart
sever
model
thu
elev
level
circul
could
viabl
option
improv
cardiopulmonari
function
clinic
set
pah
pulmonari
fibrosi
pf
devast
diseas
mark
scar
lung
tissu
recent
research
emphas
contribut
protect
pf
studi
li
et
al
first
show
lung
express
activ
sever
downregul
human
anim
model
lung
fibrosi
along
line
mice
prone
bleomycininduc
lung
injuri
convers
pulmonari
overexpress
gene
deliveri
administr
attenu
pf
collect
observ
suggest
potent
antifibrot
role
anim
model
pf
data
clearli
indic
benefici
cardiopulmonari
system
favor
effect
could
manifest
paracrinelik
manner
via
alter
local
ra
howev
indirect
effect
modul
circul
molecul
includ
ang
rule
nevertheless
appear
therapeut
potenti
may
pronounc
ang
thu
propos
multifunct
role
provid
cardiopulmonari
protect
view
support
recent
evid
oral
feed
attenu
pah
modest
increas
plasma
ang
ii
play
noncatalyt
role
gut
biolog
modul
gut
microbiota
composit
led
us
specul
benefici
effect
cardiopulmonari
system
partial
mediat
chang
gut
microbiom
research
last
year
highlight
import
nonrasrel
role
amino
acid
transport
gut
microbiota
composit
work
harmer
et
al
demonstr
high
level
express
within
human
gastrointestin
tract
suggest
function
role
system
howev
discoveri
collectrin
regul
neutral
amino
acid
transport
kidney
provid
first
evid
noncatalyt
role
similar
collectrin
type
transmembran
protein
share
ident
extracellular
transmembran
cytosol
domain
physiolog
role
collectrin
amino
acid
reabsorpt
transport
kidney
via
associ
famili
neutral
amino
acid
transport
rais
question
similar
function
one
neutral
amino
acid
transport
b
coloc
interact
small
intestin
brush
border
membran
collectrin
absent
fact
bind
stabil
b
small
intestin
transport
activ
b
dramat
stimul
coexpress
import
work
hashimoto
et
al
link
amino
acid
transport
function
microbi
ecolog
gut
studi
first
demonstr
anim
reduc
level
neutral
amino
acid
serum
specif
display
impair
uptak
tryptophan
trp
mutant
also
exhibit
decreas
express
antimicrobi
peptid
show
alter
gut
microbi
composit
restor
tryptophan
administr
interestingli
recent
studi
murr
et
al
found
coronari
arteri
diseas
cad
patient
low
serum
tryptophan
concentr
display
reduc
life
expect
find
support
idea
effect
gut
microbiota
could
posit
influenc
cv
system
hand
cardioprotect
action
could
mediat
directli
via
antimicrobi
peptid
independ
chang
gut
microbiota
antimicrobi
peptid
demonstr
effect
cardiopulmonari
system
function
antimicrobi
activ
myocardi
express
defensin
increas
follow
hypoxia
treatment
enhanc
migrat
human
circul
peripher
blood
stem
progenitor
cell
pbspc
rais
possibl
antimicrobi
peptid
may
aid
home
pbspc
injur
myocardium
anoth
antimicrobi
peptid
also
demonstr
cardioprotect
via
prevent
leukocyt
adhes
emigr
well
suppress
superoxid
releas
interestingli
role
antimicrobi
peptid
may
straightforward
alpha
defensin
one
link
atherosclerosi
cad
stsegment
elev
mi
addit
antimicrobi
peptid
highli
express
atherosclerot
plaqu
implic
modul
vessel
inflammatori
respons
taken
togeth
data
implic
antimicrobi
peptid
cardiopulmonari
health
pathophysiolog
action
may
one
mechan
mediat
protect
effect
gut
microbiom
emerg
critic
player
health
diseas
report
drawn
associ
intestin
dysbiosi
metabol
diseas
includ
obes
type
diabet
consid
major
risk
factor
develop
cvd
recent
studi
group
also
demonstr
link
gut
dysbiosi
hypertens
find
consist
clinic
studi
suggest
consumpt
probiot
improv
cv
health
name
probiot
report
reduc
bp
decreas
oxid
stress
posit
alter
cholesterol
concentr
releas
aceinhibit
peptid
recent
alter
gut
microbiota
directli
implic
pathogenesi
cvd
instanc
infant
congenit
heart
defect
show
reduc
total
bacteri
count
compar
healthi
infant
atherosclerot
plaqu
found
hous
microbiob
furthermor
administr
probiot
success
decreas
bp
delay
develop
hf
rat
follow
mi
interestingli
bp
reduct
may
mediat
effect
probiot
autonom
neurotransmiss
support
hypothesi
intraduoden
inject
lactobacillu
johnsonii
result
reduc
renal
sympathet
nerv
activ
increas
gastric
vagal
nerv
activ
consist
find
other
report
commun
nervou
system
microbiota
may
occur
via
affer
sensori
neuron
gut
fact
evid
stressinduc
intestin
permeabl
allow
enhanc
uptak
bacteri
antigen
allow
modul
central
nervou
system
immun
enter
nervou
system
pathway
believ
probiot
may
attenu
stressinduc
hyperperm
collect
data
rais
question
whether
benefici
effect
enhanc
express
activ
hf
hypertens
partli
result
alter
gut
microbiota
subsequ
modifi
autonom
input
cn
respiratori
tract
hous
microbiom
dickson
et
al
propos
model
inflamm
respons
trigger
alter
lung
condit
affect
abil
variou
microb
immigr
elimin
thu
favor
growth
microb
other
support
studi
demonstr
lung
dysbiosi
exacerb
respiratori
diseas
specif
progress
idiopath
pf
associ
increas
presenc
staphylococcu
streptococcu
bacteria
interestingli
pulmonari
dysfunct
often
relat
bowel
diseas
howev
connect
lung
gut
complet
understood
recent
work
investig
microbiom
infant
cystic
fibrosi
discov
overlap
bacteri
genera
present
gut
respiratori
tract
popul
chang
similarli
time
addit
numer
studi
demonstr
entericallyadminist
probiot
prevent
upper
respiratori
tract
infect
though
studi
address
mechan
behind
observ
pulmonari
benefit
specul
probiot
could
modul
gut
microbiom
favor
alter
nervou
system
circul
cell
exert
respiratori
protect
addit
benefit
may
result
direct
connect
gut
lung
microbiom
interest
investig
whether
benefit
pulmonari
diseas
may
mediat
via
modul
gut
andor
lung
microbiota
popul
treatment
demonstr
protect
varieti
experiment
diseas
model
associ
elev
level
ang
ii
dysregul
ra
encourag
result
anim
studi
result
initi
clinic
trial
use
singl
multipl
inject
welltoler
healthi
subject
seriou
advers
effect
doselimit
toxic
current
glaxosmithklin
test
therapeut
potenti
formerli
solubl
form
acut
lung
injuri
anoth
trial
evalu
treatment
pah
clinicaltrialsgov
although
clinic
trial
appear
sever
limit
undermin
success
protein
therapeut
one
major
hurdl
high
cost
associ
recombin
protein
manufactur
furthermor
protein
stabil
repetit
intraven
administr
patient
complianc
pose
challeng
realiz
true
benefit
therapi
effect
approach
overcom
limit
protein
therapi
would
identifi
synthet
compound
enhanc
activ
endogen
protein
group
first
discov
sever
synthet
activ
employ
structurebas
drug
design
small
molecul
activ
includ
resorcinolnaphthalein
dimethyl
amino
ethyl
amino
hydroxymethyl
sulfonyl
oxi
xnt
dize
among
three
compound
observ
dize
potent
follow
xnt
final
resorcinolnaphthalein
dize
antiprotozoan
chemotherapeut
agent
shown
exert
benefici
effect
heart
lung
diseas
exampl
dize
provid
cardioprotect
effect
rodent
model
mi
effect
prevent
develop
pah
mct
bleomycin
hypoxia
model
similarli
chronic
treatment
spontan
hypertens
rat
shr
xnt
prevent
increas
system
bp
along
improv
cardiac
contractil
furthermor
mctinduc
rat
model
pah
administr
xnt
result
lower
right
ventricular
systol
pressur
rvsp
surrog
marker
pulmonari
pressur
data
support
studi
use
anoth
activ
resorcinolnaphthalein
provid
protect
mctinduc
pah
improv
endotheli
function
modul
cytokin
releas
reduc
right
ventricular
hypertrophi
howev
certain
issu
hamper
success
translat
activ
clinic
xnt
undesir
pharmacokinet
profil
poor
water
solubl
requir
acid
ph
solubil
thu
make
undesir
drug
entiti
hand
dize
associ
sever
toxic
effect
chronic
dize
administr
result
renal
hepat
brain
injuri
could
lifethreaten
besid
dize
mutagen
teratogen
nonetheless
xnt
dize
could
serv
lead
molecul
could
structur
modifi
clinic
use
recent
report
batll
group
challeng
idea
benefit
xnt
dize
mediat
via
activ
use
vivo
mous
experi
shown
bplower
effect
xnt
block
inhibitor
xnt
decreas
bp
even
anim
furthermor
xnttreat
anim
demonstr
differ
kidney
serum
activ
plasma
ang
ii
level
plasma
ang
level
compar
control
addit
neither
xnt
dize
capabl
increas
activ
vitro
ex
vivo
stark
contrast
data
publish
group
other
demonstr
abil
activ
enhanc
enzymat
activ
vitro
vivo
number
public
record
vitro
increas
enzymat
activ
follow
incub
xnt
dize
resorcinolnaphthalein
similar
result
obtain
vivo
studi
well
xnt
shown
increas
activ
thrombi
cardiac
tissu
hypertens
rat
addit
administr
dize
increas
activ
retina
kidney
lung
heart
plasma
xnt
dize
found
significantli
increas
plasma
ang
level
indic
direct
effect
small
molecul
recent
studi
demonstr
restor
impair
endothelialdepend
relax
edr
dbdb
mice
dize
treatment
group
show
ang
dize
rescu
edr
aorta
anim
moreov
protect
effect
xnt
endotheli
function
mctinduc
pah
attenu
coadministr
masr
antagonist
likewis
benefit
resorcinolnaphthalein
pah
dize
cerebr
ischemia
abolish
blockag
masr
coadministr
inhibitor
also
block
posit
effect
dize
pah
furthermor
dize
fail
elicit
benefici
effect
cholesterol
metabol
abdomin
aortic
aneurysm
mice
recent
discoveri
novel
activ
provid
addit
support
idea
activ
inde
enhanc
activ
vitro
vivo
mountain
data
provid
evid
compound
inde
activ
howev
rule
potenti
offtarget
effect
xnt
dize
addit
activ
observ
discrep
may
attribut
differ
dosag
durat
drug
administr
anim
strain
use
differ
experiment
protocol
pharmacotherapi
includ
beta
blocker
acei
arb
antimineralocorticoid
use
attenu
maladapt
cardiac
remodel
associ
variou
hd
addit
intervent
surgic
method
employ
improv
heart
function
despit
therapi
prognosi
patient
diagnos
hf
remain
poor
result
research
explor
cellbas
therapi
mean
regener
damag
myocardium
context
administr
epc
bmor
adiposederiv
msc
umbil
cord
blood
cell
evalu
potenti
offer
cardioprotect
howev
mani
hurdl
still
exist
benefit
cell
therapi
human
may
fulli
realiz
exampl
hostil
environ
injur
tissu
character
inflamm
high
oxid
stress
could
impair
engraft
inject
progenitor
stem
cell
believ
overexpress
cell
could
improv
surviv
enhanc
potenti
effect
repair
tissu
injuri
fact
shown
prime
epc
enhanc
function
also
increas
therapeut
efficaci
render
protect
stroke
recent
umbil
cordor
bmderiv
msc
effect
rescu
lung
injuri
compar
msc
alon
autolog
stem
cell
transfer
attract
clinic
therapi
elimin
possibl
advers
immun
respons
host
also
overcom
toxic
immunosuppress
medic
believ
improv
function
progenitorstem
cell
genet
modif
may
hold
promis
treat
cardiopulmonari
disord
prefer
mean
drug
administr
via
mouth
howev
therapeut
protein
given
oral
due
degrad
acid
environ
gastrointestin
tract
overcom
issu
develop
oral
deliveri
platform
util
transplastom
technolog
bioencapsul
within
plant
leav
product
therapeut
protein
use
transplastom
technolog
multipl
benefit
convent
transgen
plant
mammalian
system
includ
high
express
transgen
abil
produc
bulk
low
mainten
cost
requir
use
operon
express
multipl
gene
simultan
minim
risk
contamin
human
pathogen
improv
biolog
contain
due
matern
inherit
plastid
major
advantag
technolog
chloroplast
express
enabl
bioencapsul
within
plant
cell
protect
gastric
enzymat
degrad
upon
oral
deliveri
observ
oral
feed
rat
bioencapsul
attenu
mctinduc
pah
associ
improv
right
heart
function
oral
deliveri
platform
hold
great
potenti
clinic
develop
therapi
evid
present
reinforc
idea
enhanc
vasoprotect
ra
compon
particularli
critic
futur
cardiopulmonari
diseas
therapi
although
exact
mechan
action
unknown
like
consequ
catalyt
noncatalyt
activ
current
therapi
focus
improv
enzymat
activ
howev
given
abil
modul
gut
microbiota
anticip
futur
therapi
may
also
target
nontradit
aspect
function
influenc
bodi
system
subsequ
implic
cardiopulmonari
health
sn
sympathet
nervou
system
